The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy Giacoppo S, Ruscica M, Grimaldi LM, Bramanti P,
Read moreProlonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness Bagnato S, Grimaldi LME, Di Raimondo G, Sant’Angelo A, Boccagni
Read moreMultiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes Martinelli V, Dalla Costa G, Messina MJ, Di Maggio G, Sangalli F,
Read moreLong-term efficacy and safety of anakinra in a patient with Behcet’s disease and concomitant tuberculosis infection Emmi G, Silvestri E, Squatrito D, Vitale A,
Read more
